# Pelthos Therapeutics Inc.: Form 8-K, filed Jul 2, 2025

- Company: [Pelthos Therapeutics Inc.](/companies/pths.md) (CIK 1919246)
- Form: 8-K
- Filed: 2025-07-02
- Accepted by EDGAR: Jul 2, 2025, 17:22 ET
- Period: 2025-07-01
- Accession: 0001753926-25-001055
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001055/g084856_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001055/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 5.01: Change in control
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1919246/000175392625001055/g084856_8k.htm

Filed Jul 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001753926-25-001055. Last ingested by Listed: Oct 30, 2026, 16:23 ET. No prices; not investment advice.